Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

AgeX Therapeutics Q4 Sales $27.00K Down From $505.00K YoY

AgeX Therapeutics (AMEX:AGE) reported $27.00 thousand in sales this quarter. This is a 94.65 percent decrease over sales of $505.00 thousand the same period last year.

byBenzinga Newsdesk

March 29, 2022

1 minute read

AgeX Therapeutics (AMEX:AGE) reported $27.00 thousand in sales this quarter. This is a 94.65 percent decrease over sales of $505.00 thousand the same period last year.

26 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 2:53 AM

Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss.

ABCL

FDA
News

Sientra Receives Regulatory Approval To Market Breast Implants In Canada

By Benzinga Newsdesk

Today, 2:53 AM

Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that it has received approval

SIEN

Earnings

Simpson Manufacturing Co Earnings Preview

By Benzinga Insights

Today, 2:53 AM

On Monday, July 26, Simpson Manufacturing Co (NYSE:SSD) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

SSD

PreMarket Prep Charts Wynn Resort’s Much-Needed Rally

By Joel Elconin

Today, 2:53 AM

One of the worst-performing sectors since 2014 has been the casino industry.

WYNN

AgeX Therapeutics Q4 Sales $27.00K Down From $505.00K YoY

Related Posts

26 Stocks Moving in Wednesday’s Pre-Market Session

Sientra Receives Regulatory Approval To Market Breast Implants In Canada

Simpson Manufacturing Co Earnings Preview

PreMarket Prep Charts Wynn Resort’s Much-Needed Rally